Further support for the role that IGF‐I is playing in lung fibroproliferation comes from Choi et al. (2009), where use of an IGF‐IR tyrosine kinase receptor blocker in a bleomycin model of lung fibrosis in mice resulted in less fibrosis when compared with controls. The gene discussed is NTRK1; the disease is pulmonary fibrosis.